Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in First-Line Antiretroviral Therapy in Settings without Virological Monitoring

Overview of attention for article published in PLOS ONE, August 2012

Altmetric Badge

Mentioned by

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 144,799 followers.

Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in 1st-Line ART in Set w/o Virological Monitoring http://t.co/cf9I68AR

Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in 1st-Line ART in Set w/o Virological Monitoring http://t.co/cf9I68AR

#PLOS: TDF cost-effective compared to AZT in first-line ART - but we need real data on treatment outcomes & resistance http://t.co/4Zkc0svr

Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in 1st-Line ART in Set w/o Virological Monitoring http://t.co/bD8KBZuN